help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Petraglia, F.
Right arrow Articles by Vale, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Petraglia, F.
Right arrow Articles by Vale, W.

Endocrinology, Vol 124, 2016-2022, Copyright © 1989 by Endocrine Society


ARTICLES

Identification of immunoreactive neuropeptide-gamma in human placenta: localization, secretion, and binding sites

F Petraglia, L Calza, L Giardino, S Sutton, P Marrama, J Rivier, AR Genazzani and W Vale
Department of Obstetrics and Gynecology, University of Modena School of Medicine, Italy.

The aim of the present study was to evaluate the possible presence of immunoreactive neuropeptide-gamma (irNPY) in human placenta. Acidic extracts of human placental tissue collected at term pregnancy contained high irNPY concentrations. The extracted irNPY eluted from HPLC with the same retention time as synthetic NPY. The presence of the peptide in placental cells was confirmed by immunohistochemical findings showing numerous cells of the cytotrophoblast layer positively staining for NPY. Further supporting local production of the peptide, primary cultures of human placental cells released irNPY into the culture medium and the addition of high K+ concentrations increased the release of the peptide. The finding of irNPY in human placenta stimulated the characterization of binding sites of NPY in the same tissue. Using autoradiographic techniques we showed specific binding of [125I]NPY in human placental tissue. The binding of [125I]NPY to the placental receptors was saturable and widely distributed within the placental tissue. Finally, the addition of NPY to the medium of cultured placental cells increased the release of immunoreactive CRF, suggesting a possible role of NPY in placental hormone production. The effect of NPY was dose related and augmented by the addition of norepinephrine (10 nM). These results showed that human placenta produces and secretes irNPY and that NPY receptors are present in placental tissue. Moreover, the evidence that NPY stimulated the release of immunoreactive CRF from cultured placental cells suggests an action of NPY in placental hormonogenesis.


This article has been cited by other articles:


Home page
Hum Reprod UpdateHome page
C. Ferretti, L. Bruni, V. Dangles-Marie, A.P. Pecking, and D. Bellet
Molecular circuits shared by placental and cancer cells, and their implications in the proliferative, invasive and migratory capacities of trophoblasts
Hum. Reprod. Update, March 1, 2007; 13(2): 121 - 141.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
P. Florio, A. Mezzesimi, V. Turchetti, F. M. Severi, C. Ticconi, S. Forconi, and F. Petraglia
High Levels of Human Chromogranin A in Umbilical Cord Plasma and Amniotic Fluid at Parturition
Reproductive Sciences, January 1, 2002; 9(1): 32 - 36.
[Abstract] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
J. Robidoux, L. Simoneau, S. St-Pierre, H. Ech-Chadli, and J. Lafond
Human syncytiotrophoblast NPY receptors are located on BBM and activate PLC-to-PKC axis
Am J Physiol Endocrinol Metab, March 1, 1998; 274(3): E502 - E509.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society